Physician profile
Norman Rowe
NPI 1598788127
$1,865.91
in general payments reported to CMS, 2019-2025
13 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,086 · 2020: $249 · 2021: $34.67 · 2022: $162 · 2023: $65.05 · 2024: $120 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $798.10 | 2019-2023 | Xeomin |
| Sientra, INC. | $276.77 | 2019-2022 | |
| Galderma Laboratories, L.P. | $226.00 | 2019-2024 | |
| Allergan, INC. | $151.39 | 2019-2022 | |
| Abbvie INC. | $76.62 | 2023-2024 | Natrelle Saline-Filled Breast Implants |
| Axogen | $76.02 | 2019 | |
| Motiva USA, LLC | $65.20 | 2025 | |
| Revance Therapeutics, INC. | $48.74 | 2024-2025 | Daxxify |
| Integra Lifesciences Corporation | $36.82 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Davol INC. | $34.51 | 2022 | |
| Fortovia Therapeutics, INC. | $32.31 | 2019-2020 | |
| Becton, Dickinson and Company | $22.11 | 2024 | Channel Drain |
| Ethicon US, LLC | $21.32 | 2025 | Stratafix, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.